Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Recruiting 4Terminated 3Active not recruiting 3Not yet recruiting 2Completed 2Available 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 359Other hematologic neoplasm 279Plasma cell 185Sarcoma 138CNS 108Myeloid 96Gynecologic 95Dermatologic 78Genitourinary 75Gastrointestinal 69Head & Neck 56Breast 49Thoracic 38Classical hematology 23Other solid neoplasm 7Other neoplasm 7Other 3Endocrine 2

Conditions

Neuroendocrine Tumors 208Multiple Endocrine Neoplasia Type 1 130Thyroid Cancer, Papillary 78Pituitary Neoplasms 68Thyroid Neoplasms 59Pheochromocytoma 55Carcinoma, Neuroendocrine 49Neoplasms 48Carcinoid Tumor 48Carcinoma, Medullary 35Adrenocortical Carcinoma 35Adenocarcinoma, Follicular 34Pancreatic Neoplasms 33Thyroid Carcinoma, Anaplastic 30Neoplasm Metastasis 27Carcinoma, Non-Small-Cell Lung 27Insulinoma 26Breast Neoplasms 25Paraganglioma 24Melanoma 23Colorectal Neoplasms 23Colonic Neoplasms 23Carcinoma, Renal Cell 23Adenoma, Islet Cell 23Somatostatinoma 22Adrenal Gland Neoplasms 22Sarcoma 21Carcinoma, Islet Cell 21Prostatic Neoplasms 20Glucagonoma 19

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Recurrence × Endocrine × Clear all
NCT03723499 2018-10-29

Endoscopic Treatment of Bronchial Carcinoid Tumors

Centre Hospitalier Universitaire de Saint Etienne

Completed
70 enrolled
Endocrine

Carcinoid Tumor, Recurrence

NCT01413503 2018-09-18

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

University of California, San Francisco

Phase 2 Completed
50 enrolled 7 charts
CNSEndocrine

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡